Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Delayed Quote USD

908 Devices Inc. (MASS)

Compare
3.8100
+0.0700
+(1.87%)
At close: April 4 at 4:00:02 PM EDT
3.8000
-0.01
(-0.26%)
After hours: April 4 at 6:43:54 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Kevin J. Knopp Ph.D. Co-Founder, CEO, President & Director 761.12k -- 1972
Mr. Joseph H. Griffith IV CFO & Treasurer 491.89k -- 1975
Mr. Michael S. Turner Esq., J.D. Chief Legal & Administrative Officer and Secretary 470.65k -- 1967
Ms. Barbara Russo VP of Marketing & Corporate Communications -- -- 1963
Mr. Don Osmer Vice President of Human Resources -- -- 1965

908 Devices Inc.

645 Summer Street
Boston, MA 02210
United States
857 254 1500 https://908devices.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
246

Description

908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Corporate Governance

908 Devices Inc.’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 3; Board: 6; Shareholder Rights: 8; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 28, 2025 at 12:30 PM UTC - May 2, 2025 at 12:30 PM UTC

908 Devices Inc. Earnings Date

Recent Events

March 7, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 8, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

October 24, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

August 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 9, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

July 8, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

June 25, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers